Pin

COVAXIN can’t become public before 2021 – India

Officials said, that people must wait till 2021 first quarter in order to get vaccine working and get all healed. According to them this is the shortest possible time to get vaccine practically ready.  The news comes days after the Parliamentary standing committees had begun to resume work after a long spell of hibernation.

Pin
COVAXIN can’t become public before 2021 – India

Covaxin or COVID – 19 Vaccine is going to be developed by Government’s Medical Research body, Indian Council of Medical Research (ICMR). They targeted to get the vaccine working by 15th of august, however now it had to be delayed for practical use.

Indian Government’s Principal Scientific Advisor – Professor Krishnaswamy VijayRaghavan, was present in the meeting. Representatives of Council of Scientific and Industrial Research (CSIR), the Department of Science and Technology and the Department of Biotechnology were also present.

ICMR clarified that, “it was all, meant to cut unnecessary red tape, without bypassing any necessary process, and speed up recruitment of participants”.

Members of committe were believed to have raised specific questions about recent claims made by yoga guru Ramdev who launched Coronil, claiming it can treat coronavirus, only to retract later.

Meanwhile, researchers in India are all set to start human trials of India’s first indigenous coronavirus vaccine candidate – COVAXIN.

Seniors & Officials at the comitee told that they are  hopeful and optimistic about India’s chances of inventing the vaccine that will be able to treat Corona Virus. This Committee was led by Congress MP Jairam Ramesh.

Bharat Biotech MD Dr Krishna Ella, tells Times Now Digital why he believes COVAXIN, India’s first indigenous coronavirus vaccine, created by the firm will work against the SARS-CoV-2

Hyderabad: Earlier this week, COVAXIN developed by leading vaccine maker Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV), became India’s first indigenous vaccine against the novel coronavirus now called the SARS-CoV-2 to get the approval for human clinical trials from the drug regulator. The Hyderabad-based biotech firm has been given the go-ahead by the DCGI to conduct phase 1 and 2 clinical trials of its COVID-19 vaccine candidate after preclinical studies demonstrated safety and effective immune response.

16 thoughts on “COVAXIN can’t become public before 2021 – India”

  1. ห่วย says:

    247011 1264Nice write-up. It does shed some light on the problem. By the for those interested in binary options can get an exclusive binary options bonus. 677442

  2. Rescue Tow West Sacramento says:

    136998 728918Hi, you used to write superb articles, but the last several posts have been kinda boring I miss your super writing. Past several posts are just slightly out of track! 180451

  3. bmo bank says:

    867437 44827Cheapest player speeches and toasts, or maybe toasts. continue to be brought about real estate . during evening reception tend to be likely to just be comic, witty and therefore instructive as properly. greatest man speeches free of charge 634878

  4. buy clenbuterol online says:

    359823 943911Its genuinely a cool and useful piece of data. Im glad which you shared this valuable data with us. Please keep us informed like this. Thanks for sharing. 17947

  5. 토토사이트 says:

    422426 7221Hi, Thanks for your page. I discovered your page through Bing and hope you maintain providing much more great articles. 426844

  6. Notizie informatiche says:

    770599 290200I think this website contains some quite very good info for everybody : D. 739889

Leave a Reply

Knowasiak

FREE
VIEW